(2018). In vivo resistance to ceftolozane/tazobactam in pseudomonas aeruginosa arising by ampc- and non-ampc-mediated pathways.
Chicago Style (17th ed.) CitationIn Vivo Resistance to Ceftolozane/tazobactam in Pseudomonas Aeruginosa Arising by Ampc- and Non-ampc-mediated Pathways. 2018.
MLA (8th ed.) CitationIn Vivo Resistance to Ceftolozane/tazobactam in Pseudomonas Aeruginosa Arising by Ampc- and Non-ampc-mediated Pathways. 2018.
Warning: These citations may not always be 100% accurate.